Journal for ImmunoTherapy of Cancer Issues Research Articles in March 2023 Edition
April 05, 2023
April 05, 2023
MILWAUKEE, Wisconsin, April 5 -- The Journal for ImmunoTherapy of Cancer, a peer-reviewed journal from the Society for Immunotherapy of Cancer that says it features all aspects of tumor immunology and cancer immunotherapy, published research articles on the following topics in its March 2023 edition:
Basic tumor immunology:
* ANXA1-derived peptide for targeting PD-L1 degradation inhibits tumor immune evasion in multiple cancers
* Identification of HPV16 E1 . . .
Basic tumor immunology:
* ANXA1-derived peptide for targeting PD-L1 degradation inhibits tumor immune evasion in multiple cancers
* Identification of HPV16 E1 . . .